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Abstract: Coffee consumption has been inversely associated with various diseases; however, the
underlying mechanisms are not entirely clear. We used data of 17,752 Third National Health and
Nutrition Examination Survey participants to investigate the association of 245 metabolites, nutrients,
and lifestyle factors with coffee consumption. We used data from the first phase (n = 8825) to
identify factors with a false discovery rate of <5%. We then replicated our results using data from
the second phase (n = 8927). Regular coffee consumption was positively associated with active and
passive smoking, serum lead and urinary cadmium concentrations, dietary intake of potassium and
magnesium, and aspirin intake. In contrast, regular coffee consumption was inversely associated
with serum folate and red blood cell folate levels, serum vitamin E and C, and beta-cryptoxanthin
concentrations, Healthy Eating Index score, and total serum bilirubin. Most of the aforementioned
associations were also observed for caffeinated beverage intake. In our assessment of the association
between coffee consumption and selected metabolites, nutrients, and lifestyle factors, we observed
that regular coffee and caffeinated beverage consumption was strongly associated with smoking,
serum lead levels, and poorer dietary habits.
Keywords: coffee consumption; environment wide association study; metabolites; nutrients; lifestyle;
National Health and Nutrition Examination Survey (NHANES)
1. Introduction
Coffee is the most widely consumed beverage worldwide [1,2], and coffee and caffeinated
beverages are some of the most studied beverages nowadays. Since its discovery, drinking coffee has
been a growing trend around the globe. Such popularity has cultivated questions on the health effects
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of its consumption. However, findings in the literature are contradicting. On one hand, coffee has been
associated with lower mortality risk [3–6] regardless of the drinkers’ genetically determined caffeine
metabolism capacity [7]. Additionally, coffee has been associated with decreased risk of dementia
and Alzheimer’s disease [8,9], Parkinson’s disease [10], type 2 diabetes [11,12], cardiovascular disease
(CVD) [13] and certain cancers such as colorectal [6,14], endometrial [6,15], prostate [6,16], and liver
cancer [17]. In contrast, studies have reported positive associations between coffee consumption and
the risk of some cancers, namely gastric [18,19] and laryngeal cancers [20]. Null associations have
been reported for esophageal [21,22] and ovarian [23–25] cancers and coffee consumption. Coffee
consumption has also been associated with increased risk of pregnancy complications [26,27] and some
CVD risk factors (e.g., higher blood cholesterol levels and blood pressure [28–30]). While some studies
have suggested a positive association [31] between coffee consumption and CVD risk, meta-analysis
studies showed that there is no risk and even demonstrated benefit of moderate coffee consumption
against CVD, all-cause mortality, and some cancers [32–34]. Furthermore, Mendelian randomization
studies have shown no causal effect of coffee consumption on CVD or all-cause mortality; U-shaped
associations were reported in observational studies [35,36].
Such heterogeneity in reported effects could be due to the underlying differences between studies.
The definition of coffee consumption is hard to harmonize, particularly due to the wide variety of coffee
types, preparation techniques, and consumption habits. For example, boiled coffee contains cafestol
and kahweol, which were implicated in the cholesterol-raising effect of coffee, and these compounds
could be removed by using brewed or filtered coffee [1].
Metabolites of caffeine and other chemical components of coffee have received much attention
because they might play a role in mechanisms of health effects and could be used as biomarkers of
coffee consumption. Their association with disease biomarkers is particularly interesting, as they
could help identify mediators between coffee consumption and positive health effects. For example,
coffee consumption was found to be inversely associated with hepatic inflammation markers [37]
and hepatocellular carcinoma [38], as well as increased insulin response [39]. The mechanism behind
the relationship between coffee and liver cancer is still unclear, but the inverse association with liver
damage markers and the positive association with antioxidants in the coffee might be part of the
answer [40,41].
Our study used an environment-wide association study (EWAS) technique to identify
the metabolites, nutrients, and lifestyle factors that are associated with coffee or caffeinated
beverage consumption.
2. Materials and Methods
2.1. Study Population
We used data from the Third National Health and Nutrition Examination Survey (NHANES III)
to investigate the association between coffee consumption and metabolites, nutrients, and lifestyle
factors. NHANES III was a cross-sectional US survey that consisted of two phases (1988–1991 and
1991–1994). The survey used representative multistage stratified, clustered probability sampling
of the US population. NHANES III data are publicly available and can be accessed online (https:
//wwwn.cdc.gov). Thus, institutional review board approval and oversight were not required for
our study.
Based on the survey design, both phases of the NHANES III can be used independently. In our
study, the first phase was used as a discovery set and the second as a replication set. Of all NHANES III
participants, only data of participants at least eighteen years old at enrollment were used in the present
study (n = 19,618). Furthermore, participants with zero weights were excluded from our analyses
leading to our final study population of 17,752 participants (nPhase 1 = 8825, nPhase 2 = 8927).
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2.2. Assessment of Coffee and Caffeinated Beverage Consumption
Habitual consumption of coffee, tea, and soda (including cola) was assessed using a food frequency
questionnaire (FFQ) that assessed the frequency (in times per month) but not the exact amount of
food consumed. The questionnaire included questions regarding consumption of caffeinated and
non-caffeinated coffee, tea, and soda. However, since consumption of non-caffeinated coffee, tea and
soda was very infrequent, we focused only on the consumption of caffeinated beverages, which we call
"regular" in the rest of the manuscript. Total caffeinated beverage consumption expressed as number
of cups per day (by assuming that the frequency reported corresponded to cups of coffee consumed
during the month), was calculated by summing the consumption of regular coffee, regular tea, regular
sodas (including colas), and diet sodas (including diet colas).
2.3. Assessment of the Metabolites, Nutrients, and Lifestyle Factors
In our analysis, we included 245 metabolites, nutrients, and lifestyle factors (29 factors on body
measurements, disease history, and medication use; 32 lifestyle factors; 80 metabolites and 104 dietary
nutrients), which have previously been assessed and are publicly available (https://wwwn.cdc.gov).
NHANES III participants were interviewed and underwent physical examinations in a mobile
examination center. Information on some factors was obtained during the interview, while others
were obtained via laboratory testing. Dietary information was collected with 24-hour dietary recall
interviews, using an automated data collection instrument [42]. All NHANES III participants were
asked to complete a 24-h dietary recall during their visit at the Medical Examination Center (MEC).
In addition, about 5% of all adult examinees received a second replicate MEC examination that included
a 24-h dietary recall; this replicate data was used to estimate within- and between-person variances for
estimating nutrient intake distributions. Data collection was scheduled as such as to include all days
of the week and throughout the year. Apart from reproductive factors, all factors were investigated in
both men and women (Supplementary Table S1). Continuous factors were Z-score standardized.
2.4. Statistical Analysis
2.4.1. Discovery Phase
Using Phase 1 of the NHANES III, we assessed the association of metabolites, nutrients, and lifestyle
factors with regular coffee consumption. Survey weighted linear regression models were used to
examine the association of regular coffee consumption (continuous, cups per month), with continuous
and dichotomous metabolites, nutrients, and lifestyle factors as explanatory variables. We then corrected
for multiple testing using false discovery rate (FDR). We estimated FDR using the Benjamini–Hochberg
step down method; factors at FDR < 0.05 were considered significant. The following factors were a
priori considered confounders rather than predictors in this study: age, sex, race/ethnicity, education,
and socioeconomic status (SES). Race/ethnicity was categorized into four groups: Non-Hispanic white,
Non-Hispanic black, Mexican–American, and Other. Education was categorized as less than high school,
high school equivalent, and higher than high school. SES was estimated using poverty-to-income ratio
(PIR), a ratio of total family income to the official poverty threshold according to the family size. A
PIR < 1 indicates that income is below the poverty threshold. We categorized PIR into four categories
(PIR < 1, 1 ≤ PIR < 2, 2 ≤ PIR < 3, and PIR ≥ 3).
2.4.2. Replication Phase
To replicate the results of the discovery phase we used data from Phase 2 of NHANES III. For the
replication, we considered only the statistically significant factors of the discovery set (FDR < 0.05).
Factors were considered relevant if their association with coffee consumption reported a p ≤ 0.05 in
the replication set. Additionally, we examined the associations between these replicated metabolites,
nutrients, and lifestyle factors and the consumption of total caffeinated beverages (continuous, cups
per month).
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Since the food group “soft drinks” includes not only caffeinated beverages, but also non-caffeinated
soft drinks, we checked their association with the replicated metabolites, nutrients, and lifestyle factors
for regular coffee consumption. We defined soft drinks as the sum of regular sodas and diet sodas and
included it as a continuous variable in our model.
In sensitivity analyses, we investigated whether the replicated metabolites, nutrients, and lifestyle
factors for regular coffee consumption were similarly associated in men and women. We used survey
weighted logistic regression to assess the sex-specific associations between dichotomized regular coffee
consumption (at least one cup per day vs. less) and the metabolites, nutrients, and lifestyle factors
replicated in the total study population. We tested for interactions with sex by adding an interaction
term in all the weighted logistic regression models between coffee consumption and the metabolites,
nutrients, and lifestyle factors replicated in the total study population.
Datasets were prepared for analysis using the Statistical Analysis Software (SAS) university
edition (SAS Institute, Cary, NC, US) and analyses were performed using R (version 3.2.1). Analyses
were performed using the survey package including sampling weights to account for the complex
survey design and survey non-response.
3. Results
Among 8292 male study participants, 4111 consumed one cup of coffee or more per day (mean
consumption 72.4 cups per month), and 4766 out of 9460 female participants consumed coffee at
least once per day (mean consumption 62.0 cups per month; Table 1). The mean age of daily coffee
drinkers was 46.6 years for men and 48.6 years for women; non-daily drinkers were younger than daily
drinkers. Mean body mass index (BMI) was 26.6 kg/m2 for men and 26.3 kg/m2 for women, which was
similar between daily and non-daily coffee drinkers. Daily coffee consumption was more common in
Non-Hispanic whites than in Non-Hispanic blacks and in participants with higher SES as indicated by
the PIR. Distribution of studied metabolites, nutrients, and lifestyle factors in men and women are
provided as supplementary material (Supplementary Table S1).
Table 1. Baseline characteristics of study participants, the Third National Health and Nutrition




<1 cup/day ≥1 cup/day <1 cup/day ≥1 cup/day
No. study participants 1 (%) 4163 (50.31) 4111 (49.69) 5182 (54.86) 4264 (45.14)
Age, mean (SE), years 38.64 (0.49) 46.61 (0.51) 41.15 (0.53) 48.62 (0.56)
BMI, mean (SE), kg/m2 26.32 (0.14) 26.59 (0.13) 26.36 (0.24) 26.31 (0.13)
Race/Ethnicity, %
Non-Hispanic White 69.52 81.99 71.16 80.84
Non-Hispanic Black 15.45 5.79 15.48 7.72
Mexican–American 6.27 5.11 4.99 4.44
Other 8.76 7.11 8.36 7.00
Education, %
Less than high school 9.45 13.25 10.27 12.51
High school equivalent 45.82 45.76 48.90 51.99
Higher than high school 44.73 40.99 40.83 35.50
PIR category, %
PIR < 1 12.18 10.24 17.16 12.40
1 ≤ PIR < 2 21.83 18.47 22.36 22.27
2 ≤ PIR < 3 21.98 21.76 20.81 19.70
PIR ≥ 3 44.01 49.53 39.67 45.63
1 Number of study participants is unweighted. Abbreviations: BMI, body mass index; SE, standard error; PIR,
poverty-to-income ratio.
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3.1. Discovery Phase
We performed a systematic screening of associations between the metabolites, nutrients,
and lifestyle factors with regular coffee and total caffeinated beverage consumption. Out of the
245 metabolites, nutrients, and lifestyle factors initially investigated, 32 factors were identified in the
discovery set with FDR < 0.05 (Figure 1; Supplementary Table S2).
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Figure 1. Manhattan plot depicting the associations between metabolites, nutrients, and lifestyle factors
and coffee consumption in the discovery phase. Factors were ordered based on the size of effects
(beta coefficient). Variable names are given only for the statistically significant metabolites, nutrients,
and lifestyle factors.
3.2. R plication Phase
Table 2 shows the 30 factors replicated that were significantly associated with regular coffee
consumption. To summarize, coffee consumption was positively associated with both active and
passive smoking, serum lead and urinary cadmium concentrations, aspirin use during the last month,
and intake of magnesium, potassium, and water. It was inversely associated with folate levels in serum
and red blood cells, serum concentrations of vitamin E and C and beta-cryptoxanthin, serum total
bilirubin, Healthy Eating Index, and fruit intake (as assessed by the Healthy Eating Index). Most of
these factors were also associated with intake of total caffeinated beverages, although not all replicated
factors were statistically significant (Table 3). The association between soft drinks intake and factors
replicated for regular coffee consumption were of the same direction as for regular coffee consumption
(i.e., inverse association for vitamin serum levels and the Healthy Eating Index; positive association for
passive smoking), but we did not se statistically significant associations with facto s rel ted to active
smoking, besides former sm k ng.
In sex-specific analyses, all p-values for interactions were <0.05. However, the as oc ation between
th replicated factors for regular coffee consumption identified in the replication phase and daily coffee
consumption was similar in men and in women (Supplementary Table S3), with most replicated factors
for regular coffee consumption showing up as statistically significant.
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Table 2. Replicated metabolites, nutrients, and lifestyle factors associated with regular coffee
consumption (assessed as a continuous variable).
Factor No. 1 Coefficient SE p-Value
Water (gm) 2 7681 13.01 2.42 1.67 × 10−4
Caffeine (mg) 2 7681 21.57 2.70 3.78 × 10−6
Smoked 100+ cigarettes in life (yes, no) 8138 21.58 2.26 6.01 × 10−7
Age first smoked cigarettes regularly
(<30, 30–40, 40–50, >50)
8002 9.68 1.06 9.38 × 10−7
Number of cigarettes smoked per day 1801 10.36 3.25 7.83 × 10−3
Former smoking (vs. never smoking) 6215 10.49 1.73 5.69 × 10−5
Current smoking (vs. never smoking) 6248 34.79 4.09 1.97 × 10−6
Smoked at least 20 cigars in life (yes, no) 8135 14.40 5.16 1.63 × 10−2
Smoked 20 pipes of tobacco in life (yes, no) 8135 19.34 6.90 1.60 × 10−2
Serum cotinine (ng/mL) 7603 12.25 1.78 1.68 × 10−5
Does anyone smoke at home? (yes, no) 8138 21.34 2.34 9.40 × 10−7
Can smell smoking in office? (yes, no) 4467 15.86 4.44 3.86 × 10−3
Number of persons who smoke at home 8138 11.24 1.66 1.99 × 10−5
Hours per day can smell smoking at work 4467 8.30 2.48 5.79 × 10−3
Took aspirin in last month (yes, no) 8127 5.46 2.43 4.47 × 10−2
Serum Lead Concentration (ug/dL) 7866 8.25 1.71 4.23 × 10−4
Urinary cadmium (ng/mL) 7783 4.04 1.52 2.11 × 10−2
Serum total bilirubin (mg/dL) 7771 −4.73 1.29 3.27 × 10−3
Serum beta cryptoxanthin (ug/dL) 7791 −4.62 0.88 2.16 × 10−4
RBCs folate (ng/mL) 7632 −6.04 0.56 1.70 × 10−7
Serum folate (ng/mL) 7824 −4.03 1.27 8.08 × 10−3
Serum vitamin C (mg/dL) 7372 −4.21 0.72 7.57 × 10−5
Serum vitamin E (ug/dL) 7792 −3.25 0.95 4.94 × 10−3
Fruits, Healthy Eating Index Score 2 7681 −4.06 1.07 2.62 × 10−3
Healthy Eating Index Score 2 7681 −5.03 0.99 2.82 × 10−4
Energy from carbohydrate (%kcal) 2 7681 −5.17 1.50 4.86 × 10−3
Fructose (gm) 2 7681 −5.28 0.82 3.22 × 10−5
Glucose (gm) 2 7681 −5.09 0.99 2.53 × 10−4
Magnesium (mg) 2 7681 4.35 1.58 1.75 × 10−2
Potassium (mg) 2 7681 5.45 1.53 3.89 × 10−3
1 Number of study participants is unweighted. 2 Assessed from 24-hour dietary recall interviews. Abbreviations:
gm, gram; mg, milligram; RBCs, red blood cell; SE, standard error.
Table 3. Replicated metabolites, nutrients, and lifestyle factors of regular coffee consumption and their
association with consumption of caffeinated beverages and soft drinks (continuous).
Caffeinated Beverages Soft Drinks
Factor Coefficient SE p-Value Coefficient SE p-Value
Water (gm) 1 19.64 2.07 6.32 × 10−7 3.46 0.82 1.20 × 10−3
Caffeine (mg) 1 – 2 –
Smoked 100 + cigarettes in life (yes, no) 26.09 3.01 1.62 × 10−6 –
Age first smoked cigarettes regularly
(<30, 30–40, 40–50, > 50)
11.73 1.48 4.19 × 10−6 –
Number of cigarettes smoked per day 17.22 2.99 8.90 × 10−5 –
Former smoking (vs. never smoking) 11.29 2.83 1.78 × 10−3 5.61 1.60 4.27 × 10−3
Current smoking (vs. never smoking) 41.76 4.81 1.60 × 10−6 –
Smoked at least 20 cigars in life (yes, no) 19.44 7.99 3.16 × 10−2 –
Smoked 20 pipes of tobacco in life (yes, no) 23.27 7.62 1.00 × 10−2 –
Serum cotinine (ng/mL) 16.01 2.07 5.29 × 10−6 2.63 0.58 7.08 × 10−4
Does anyone smoke at home? (yes, no) 29.11 3.25 1.16 × 10−6 4.61 1.27 3.51 × 10−3
Can smell smoking in office? (yes, no) 22.76 5.93 2.35 × 10−3 –
Number of persons who smoke at home 14.86 2.49 6.53 × 10−5 2.40 0.73 6.34 × 10−3
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Table 3. Cont.
Caffeinated Beverages Soft Drinks
Factor Coefficient SE p-Value Coefficient SE p-Value
Hours per day can smell smoking at work 13.27 2.78 4.53 × 10−4 –
Took aspirin in last month (yes, no) – –
Serum Lead Concentration (ug/dL) 8.09 1.92 1.20 × 10−3 –
Urinary cadmium (ng/mL) 4.99 1.15 9.66 × 10−4 –
Serum total bilirubin (mg/dL) −6.58 1.63 1.61 × 10−3 –
Serum beta cryptoxanthin (ug/dL) −9.56 1.46 2.82 × 10−5 −3.43 0.54 3.64 × 10−5
RBCs folate (ng/mL) −9.99 1.02 4.55 × 10−7 −2.49 0.66 2.77 × 10−3
Serum folate (ng/mL) −7.14 1.35 1.94 × 10−4 −2.39 0.48 3.24 × 10−4
Serum vitamin C (mg/dL) −10.37 1.37 6.53 × 10−6 −4.36 0.75 8.85 × 10−5
Serum vitamin E (ug/dL) −3.96 1.48 1.99 × 10−2 –
Fruits, Healthy Eating Index Score 1 −7.86 1.60 3.57 × 10−4 −2.66 0.6 8.31 × 10−4
Healthy Eating Index Score 1 −8.87 1.70 2.19 × 10−4 −2.97 0.63 5.13 × 10−4
Energy from carbohydrate (%kcal) 1 −4.45 1.64 1.90 × 10−2 –
Fructose (gm) 1 – 2.74 0.78 4.27 × 10−3
Glucose (gm) 1 – 2.76 0.83 6.14 × 10−3
Magnesium (mg) 1 – –
Potassium (mg) 1 – –
1 Assessed from 24-h dietary recall interviews. 2 The dashed lines represent coffee-replicated factors that failed
replication in either soft drinks or caffeinated beverages consumption. Coefficients are only shown for replicated
results. Abbreviations: gm, gram; mg, milligram; RBCs, red blood cell; SE, standard error.
4. Discussion
In our systematic, cross-sectional analysis of 245 metabolites, nutrients, and lifestyle factors, using a
representative sample of the US population, regular coffee consumption was positively associated with
smoking (both active and passive), and serum lead and urinary cadmium concentrations. In contrast,
regular coffee consumption was inversely associated with serum folate, red blood cell folate levels,
and the Healthy Eating Index score.
The significant association between regular coffee consumption and smoking (active and passive)
could be explained by the stimulation of caffeine metabolism by smoking and thereby the higher
tolerance of caffeine in smokers (i.e., they may drink more coffee or caffeine-containing beverages than
non-smokers) [43–45]. According to a recent Mendelian randomization study, the amount of coffee
consumed is unlikely to significantly affect the amount of cigarette smoking [46]. The association
between coffee consumption and smoking could also be attributed to personal liability to have addictive
habits [47], or a combination of all the aforementioned mechanisms. However, in this project, we are
unable to judge the direction of the association between coffee consumption and smoking.
The positive association between regular coffee consumption and serum lead or urinary cadmium
concentrations in our study potentially reflects coffee contamination with heavy metals [48]. The inverse
association between regular coffee consumption and serum folate or red blood cell folate concentration
might indicate that coffee drinkers follow a diet less rich in fruits and vegetables compared to non-regular
coffee drinkers. An inverse association between coffee consumption and folate concentration was also
reported in a Norwegian study [49]. Alternately, this inverse association might be attributed to altered
nutrient metabolism due to coffee consumption.
Most factors associated with regular coffee consumption were also associated with total intake of
caffeinated beverages, with the exception of fructose, glucose, magnesium, and potassium (as assessed
from the 24-h dietary recall). As expected, fructose and glucose intake were positively associated with
the consumption of soft drinks. Soft drinks were also inversely associated with circulating levels of
folate, vitamin C and vitamin E, but not with smoking, indicating that soft drinks per se do not drive
the association between the replicated factors for regular coffee consumption and the total caffeinated
beverage consumption. A genome-wide association study, reporting no association between the genetic
risk for coffee consumption and soft drink consumption, supports this finding [50].
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Associations between coffee consumption and favorable metabolic profile (i.e., oxidative
stress [40,51], hepatic function [37,52], or metabolic syndrome [53,54] markers) have been reported in
the literature. These associations potentially explain the protective effect of coffee consumption on
various diseases, including type 2 diabetes [11,12], different cancers [5,6,14–17,38] and mortality [5,6].
We acknowledge that our analysis did not detect similar significant associations. This could reflect the
diversity in coffee composition (differences by type of coffee, preparation of coffee etc.) and the need
for better-powered studies that are able to detect significant associations of smaller effect size.
To our knowledge, this is the first study that systematically looked at the cross-sectional association
between coffee consumption and various metabolites, nutrients, and lifestyle factors simultaneously.
Such associations have been the center of interest in clinical research but with reporting of only a limited
group of metabolites, nutrients, or lifestyle factors in most studies. With our approach, we intended to
find associations between coffee consumption and markers/indicators that represent coffee metabolites
without having a specific disease in mind, thus, avoiding selective reporting and false positive results.
Identifying coffee metabolites and using them as surrogates of coffee consumption or as surrogates
of a certain component in coffee can help avoid misclassification bias. Our systematic approach to
test associations of multiple factors with coffee or caffeinated beverage consumption allowed us to
avoid selective testing of certain factors, which could be a source of bias and false positive results.
Additionally, the detailed information collection at baseline allowed us to adjust for major confounders
and we further replicated our results in a different dataset to verify the strong statistical associations of
the results reported.
Using NHANES III as a representative sample of the US population allowed for generalizability
of our results; however, since this is a cross-sectional study, causality cannot be assessed. Some of the
tested factors were self-reported, and dietary intake was mainly assessed using an FFQ that asked for
frequency of consumption but not portion size. This could have resulted in misclassification not only
in coffee and other beverage intake but also in confounding variables. Additionally, no information
was available on the caffeine content of soft drinks. Finally, the wide variety of coffee types, cup
sizes, and preparation techniques makes it challenging to accurately classify coffee consumption into
subgroups or to accurately estimate caffeine intake.
Acknowledging these limitations, we showed a systematic approach for testing the
metabolites, nutrients, and lifestyle factors associated with coffee and related beverage consumption.
These associations could pave the way for future studying of the benefits and risks of these beverages
and their relations to diseases and mortality.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/12/5/1470/s1:
Table S1. Survey weighted descriptive statistics of metabolites, nutrients, and lifestyle factors in the Third National
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reported for continuous variables while proportions are reported for categorical variables; Table S2. Associations
between metabolites, nutrients, and lifestyle factors and regular coffee consumption in the discovery set. All
models were adjusted for age, race/ethnicity, education, and poverty-to-income ratio (PIR). Benjamini–Hochberg
adjusted p-values for false discovery rate (FDR) < 5% are shown; Table S3. Validated metabolites, nutrients,
and lifestyle factors of regular coffee consumption and their association with coffee consumption (continuous)
stratified by sex.
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